Earnings call transcript: Vext Science Q4 2024 sees revenue growth

Vext Science Inc. (VEXT), a cannabis company with a market capitalization of $30.24 million, reported its financial results for the fourth quarter of 2024, showcasing a notable increase in revenue and adjusted EBITDA. The company achieved a 13% sequential revenue growth in the quarter, reaching $10.2 million, while the full year revenue increased by 3.4% to $36 million. Despite these positive results, the company’s stock experienced a slight decline of 2.78% following the announcement, closing at $0.245. According to InvestingPro data, the stock has shown significant volatility with a beta of 1.74, suggesting higher risk compared to the market.

Key Takeaways

• Vext Science reported a 13% sequential increase in Q4 2024 revenue.
• Full year adjusted EBITDA saw a significant 66% year-over-year growth.
• The company is expanding its cultivation capacity and dispensary licenses in Ohio.
• Market challenges include pricing pressures and oversupply in the cannabis sector.
• The stock price dropped by 2.78% post-announcement.

Company Performance

Vext Science demonstrated strong financial performance in Q4 2024, with a sequential revenue increase of 13% to $10.2 million. The full year revenue rose by 3.4% compared to 2023, indicating steady growth. The company’s adjusted EBITDA for the year surged by 66% year-over-year, highlighting improved operational efficiency. These results are achieved amidst challenging market conditions, including pricing pressures and oversupply in the cannabis industry.

Financial Highlights

• Revenue: $10.2 million in Q4 2024, up 13% sequentially.
• Full year 2024 revenue: $36 million, a 3.4% increase from 2023.
• Adjusted EBITDA: $3.2 million in Q4 2024, marking the strongest quarter in over two years.
• Cash flow from operations: $4 million in Q4 2024.
• Cash on hand: $4.6 million as of December 31, 2024.

Outlook & Guidance

Looking ahead, Vext Science plans to continue its expansion in Ohio, focusing on increasing cultivation capacity and optimizing operations in Arizona. The company targets full debt elimination by the end of 2026 and anticipates further cash flow growth. Market stabilization is also expected as the company navigates regulatory uncertainties and evaluates potential market entry into Kentucky.

Executive Commentary

CEO Eric Hoffendurger noted, "2024 was a pivotal year for Vext," emphasizing the importance of price in the current market environment. CFO Trevor Smith added, "Our vertically integrated model enables us to optimize price, preserve margins and remain agile," reflecting the company’s strategic focus on maintaining competitiveness.

Risks and Challenges

• Pricing pressures across the cannabis market could impact margins.
• Market oversupply remains a challenge, potentially affecting sales.
• Regulatory uncertainties in Ohio may pose operational risks.
• The Arizona market has experienced a 12.6% sales decline.
• Capital expenditure plans are limited to under $2 million annually, which could constrain growth opportunities.

Q&A

During the earnings call, analysts inquired about the challenges in the Arizona market and the regulatory uncertainties in Ohio. The company confirmed its capital expenditure plans would remain under $2 million annually and is evaluating potential entry into the Kentucky market.

Full transcript - Vext Science Inc (VEXT) Q4 2024:

Conference Operator: Welcome to VEX Sciences’ Fourth Quarter and Fiscal Year twenty twenty four Financial Results Conference Call. As a reminder, all participants are in listen only mode and the conference is being recorded. After the presentation, there will be an opportunity to ask questions. I would now like to turn the conference over to Priyam Chakraborty. Please go ahead.

Priyam Chakraborty, Investor Relations/Legal Representative, VEX Sciences: Thanks, operator. Good morning, everyone, and thank you for joining us today. Vext’s fourth quarter and fiscal year twenty twenty four financial results were released earlier this morning. The press release, financial statements and MD and A are available on SEDAR Plus as well as on the WEX website at wexscience.com. We would like to remind listeners that portions of today’s discussion include forward looking statements and that forward looking statements are included in today’s filings.

There can be no assurance that these forward looking statements will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results contained therein will materialize. Risks and uncertainties that could affect future developments, circumstances or results are detailed in the MD and A and VEX other public filings that are made available on SEDAR Plus and we encourage listeners to read those risk factors in conjunction with today’s call. As a result of these risks and uncertainties, the development circumstances or results predicted in forward looking statements may differ materially from actual developments, set of examples or results. This call also includes non IFRS financial information and such non IFRS financial measures are subject to the disclosure and reconciliation included in our press release disseminated earlier today as well as the MD and A. Forward looking statements made during this conference call are made as of the date of this call.

Vext disclaims any intention or obligation to update or revise such information, except as required by applicable law. Best financial statements are presented in U. S. Dollars and the results discussed during this call are in U. S.

Dollars. I will now pass the call over to Eric Hoffendurger, Chief Executive Officer of Flex.

Eric Hoffendurger, Chief Executive Officer, VEX Sciences: Thanks Priyam. Good morning everybody and thank you for joining our fourth quarter and full year twenty twenty four financial results conference call. I’m joined today by Trevor Smith, Veth’s CFO. I will start by providing a brief overview of our progress during the fourth quarter as well as 2024. Before turning it over to Trevor for an update on our financial performance.

2024 was a pivotal year for VEX despite macroeconomic headwinds and shifting consumer behavior, BEX reinforced its operational strength and solidified its position in Arizona and Ohio. Q4 market turning point as a successful launch of Ohio’s adult use market began translating into meaningful revenue growth and increased cash flow for VEX. The fourth quarter of twenty twenty four was our first full quarter of adult use sales in Ohio which helped bolster our overall revenue generated

: to $10,200,000

Eric Hoffendurger, Chief Executive Officer, VEX Sciences: and adjusted EBITDA to $3,200,000 I’m pleased to share that Q4 of twenty twenty four was our strongest operating quarter in recent years, both in terms of adjusted EBITDA and operating cash flow. This performance was primarily driven by Ohio with our consolidated retail locations delivering 40% sequential growth in total sales in the fourth quarter of twenty twenty four and driving significant operating leverage. With additional adult use regulations still pending, we see additional upside as the market continues to evolve. While Ohio demonstrated solid performance, Arizona continued to face pricing pressure from oversupply and heightened competition. The key to success in this environment is focusing on retail.

We strongly believe that in cannabis just like many other traditional consumer goods categories, we retail price a significant portion of the economics. You have to be where consumer shop, particularly if advertising is restricted and e commerce is not the primary channel for your products. Shelf space is paramount. You can’t have a brand in this industry without that shelf space. Our view is that consumers choose a dispensary based on location, value and service.

What they walk out with is simply the product available on the shelf. Some in this space may call that branding, but without a vertical integration, in house brands and a focus on what consumers really want. Those operators often struggle to compete. That’s why we focused on capturing value at the retail level by controlling shelf space, improving customers and store experience combined with disciplined execution and prudent cost controls. We have spent several quarters investing and now we are starting to see the returns.

For 2024, FX generated revenue of $36,000,000 a 3% increase over fiscal twenty twenty three and adjusted EBITDA of $9,200,000 up 66% year over year. I’m incredibly proud of our team’s ability to retain market share in the challenging Arizona market while efficiently scaling our Ohio operations. Taking a closer look at Ohio, the market has performed largely as we had expected. According to state data, adult use cannabis sales in Ohio exceeded $2,500,000,000 as of March. Despite relatively solid top line growth, prices across most product categories have declined with over half seeing double digit price decreases.

Operating in this market proves a fundamental truth price matters a lot. And if you’re going after the mass market thinking you’ll be a premium price brand, you’re going to need to adjust your expectations. We have also always seen this as a value game like traditional high low retail. It’s all about giving customers value, driving house brand penetration and mixing back to a higher margin. The price trends we are seeing in Ohio are exactly what we observed in Arizona during its transition to an adult use market and the same story that has played out across other mature markets.

We saw this going into Ohio. We even laid it out in our investor materials before the market opened. So we’re already in position to drive results. We are in the early phases of market expansion and are well positioned to capitalize on this growth and maintain share as the market matures. As we previously demonstrated in Arizona, our disciplined strategy allows us to generate above market results even in competitive environments.

BEX operations in Ohio have performed exceptionally well with the momentum for Q3 carrying through Q4 and into early twenty twenty five. To support this growth, we continue to expand our cultivation capacity, increasing plant counts and improving yields to meet growing retail demand. Trevor will expand on this further in his remarks. Net third party wholesale sales in Ohio increased by 33% in quarter four twenty twenty four compared to quarter three twenty twenty four. While wholesale is not a primary driver of our long term revenue strategy, Ohio’s regulations for manufacturing and cultivation create significant opportunities and we expect to capitalize on the expanding market.

Just as we laid out the expectations that price will start falling, we only see wholesale as a short term driver of the business and have designed our capacity to perfectly match what we think we can sell at market maturity through our own retail doors. Looking ahead, we expect Ohio to remain a key contributor to Beck’s growth in 2025 and beyond. The acquisition of the two big Perm dispensaries in in Athens and Jeffersonville is nearing completion. As announced in our press release this morning, we have received regulatory approval from the Ohio Division of Cannabis Control and expect to complete the transaction imminently. Together with the recently announced Portsmouth location and our 10b allocation, we are on track to reach Ohio’s dispensary license cap eight with new locations set to open throughout 2025 and potentially into early twenty twenty six.

As a fully vertically integrated operator with the maximum possible license, we will be in the strongest possible position in the Ohio market and anticipate significant revenue, profitability and cash flow growth from the state in the coming years. Let’s turn to Arizona. In 2024, Arizona experienced the sixth worst year over year performance of any cannabis market in The U. S. With total statewide sales declining 12.6%.

Factoring in the increase in dispensary count for 2023, the average per store sales declined 25%. Excess cultivation capacity leading to an oversaturated brand landscape continue to create pricing pressures. Despite these headwinds, our team successfully drove traffic into stores through data driven campaigns, leveraged improved yields from our Eloy cultivation facility, maintained gross margins in a challenging market and enhanced efficiencies across the vertical footprint. On a six month basis, our retail sales in Arizona were up 2.4% compared to a statewide decline of 6.4%. A solid performance which position us to drive even better long term results as the market stabilizes and pricing pressure begins to ease.

We do not anticipate pursuing new retail acquisitions in Arizona in the near term as vendor expectations remain higher than most market conditions justify. However, as weaker operators continue to exit, we expect additional opportunities to merge and we will evaluate them when pricing and timing align with our strategy. Long term, we see significant value and additional owned retail where we can add to upstream footprint and leverage that scale. In closing, I am pleased with our performance in 2024. We executed our strategy effectively delivering strong results across our key markets and establishing VEX as one of the industry’s strongest operators relative to our size, positioning us well to drive results over the next several quarters as cash flow continues to grow and highlights how undervalued this organization is on that basis.

As we continue in 2025, our focus is clear, continued expansion in Ohio, optimizing Arizona’s vertical footprint and generating sustainable cash flow while maximizing value for our shareholders. With that, over to Trevor for a quick review of the financials. Trevor?

Trevor Smith, Chief Financial Officer, VEX Sciences: Thanks very much, Eric. VEX delivered strong financial performance in the fourth quarter and full year 2024, demonstrating continued growth and operational discipline. For fiscal twenty twenty four, we generated revenue of $36,000,000 dollars a 3.4% increase over fiscal twenty twenty three. In the fourth quarter of twenty twenty four, revenue was $10,200,000 a sequential increase of 13%. As Eric mentioned, these results were primarily driven by strong adult use sales in Ohio, which offset continued pressures in Arizona.

We expect Ohio to remain a key revenue driver as customer count increases and VEX new dispensaries come online. VEX recorded adjusted EBITDA of $3,200,000 in the fourth quarter of twenty twenty four compared to 500,000 in the fourth quarter of twenty twenty three and up 13% sequentially. This was our strongest quarter from adjusted EBITDA perspective in more than two years. For the full year, adjusted EBITDA came in at $9,200,000 a 66% increase over fiscal twenty twenty three. These strong results reflect growth from a full quarter of adult youth sales in Ohio combined with our disciplined approach to cost control.

Inventory levels remained stable during the fourth quarter of twenty twenty four compared to the third quarter of twenty twenty four, with inventory declines in Arizona offset by inventory increases in Ohio. This reflects ongoing improvements in cultivation yields, particularly in Ohio. Our Eloy cultivation facility also continues to perform exceptionally well and continue to harvest crops every other week throughout the fourth quarter of twenty twenty four. Crop yields and potency have notably improved compared to our legacy Arizona sites and now exceed industry averages. Even after the improved yields, our Arizona operations are fully sold through on flower, leaving no exposure to the Arizona flower wholesale market and the downward pricing pressures therein.

In Ohio, we are actively increasing retail sell through as well as exploring additional wholesale and white label opportunities ahead of opening our additional retail stores in the state. As Eric mentioned, we expect Ohio to follow Arizona and being fully sold there on Flower once all eight locations are open. Operating expenses during the fourth quarter in fiscal twenty twenty four remained flat. As indicated last quarter, we expect operating expenses to remain relatively stable and continue to decrease as a percentage of revenue. The efficiencies gained at Eloy, along with the monetization of our increased inventories or adult use sales in Ohio, are expected to contribute to this trend.

Cash flow from operations was $4,000,000 in the fourth quarter of twenty twenty four, compared to negative $700,000 year to date as of the third quarter of twenty twenty four, reflecting strong performance from our Ohio operations and increasing contributions from our vertically integrated footprint. Once again, the fourth quarter of twenty twenty four marked the highest quarterly cash flow from operations in three years. Cash flow from operations for the year 2024 in total were $3,300,000 dollars While this represented a twenty four percent decline compared to fiscal twenty twenty three, it was primarily due to our increased inventory investments in Ohio to support elevated adult use demand. With the rollout of adult use sales in Ohio, we

: anticipate further strengthening of cash flow

Trevor Smith, Chief Financial Officer, VEX Sciences: from operations throughout this year and into Zext ended the quarter with $4,600,000 in cash as of 12/31/2024. With a solid balance sheet entering 2025, we do not anticipate any capital raises for operational expenses or the Ohio retail expansion plans, positioning us well to continue executing on our strategic priorities. In line with our commitment to strengthening our financial position, we have prioritized debt reduction. We expect to pay down approximately $6,500,000 in non mortgage debt in 2025, keeping us on track to eliminate all non mortgage debt by the end of twenty twenty six. Additionally, we made the decision to wind down our Oklahoma joint venture and the Happy Travels joint operation in California due to ongoing market challenges and oversupply.

This resulted in a non cash impairment charge of $2,900,000 in the fourth quarter. We do not anticipate any further charges related to these wind downs. And this decision allows us to fully focus our resources on our core markets, where we see the greatest potential for long term value creation. In 2025, our focus remains on generating free cash flow to reduce debt, optimizing our Ohio and Arizona operations and positioning VEX for continued growth. Our vertically integrated model enables us to optimize price, preserve margins and remain agile in the face of challenging market conditions.

And we are confident that our disciplined approach will enable us to drive strong financial performance this year and beyond. Thanks everyone for joining us for our fourth quarter and full year twenty twenty four financial results conference call. I’ll now turn it over to the operator for your questions.

Conference Operator: We will now begin the question and answer session. The first question comes from Matt Bottomley with Canaccord Genuity. Please go ahead.

Matt Bottomley, Analyst, Canaccord Genuity: Yes, good morning everyone. Thanks for the questions here. Eric, I just wanted to expand a little, if you could, on what’s happening in Arizona. I know that on the back of COVID, there were some tourist reductions, then you had some all time weather highs a couple of years ago, maybe even into this year. And then we have overall just lower consumer spend.

So how much of this is baked in that we might expect over the years to come to unwind a little bit? Or is the pricing pressure just more simply, as you mentioned, just pure too much cultivation in the market?

Eric Hoffendurger, Chief Executive Officer, VEX Sciences: Mac, good morning. I think it’s just too much cultivation in the market. I think that’s the biggest issue that you have. I think there’s some other good stuff going on in Arizona with the state starting to address the hemp market, some of those other things. We still have a big black market issue out here, just like you do everywhere else.

I think that as the consumers press for cash, avoidance of tax is something that’s of value to them. So I think you’re going to be facing that. That said, I think that you’re seeing some disruption or some people with attrition. My biggest issue in this space is that from an asset standpoint, it’s where do the assets go. So they seem to pop back up.

So if somebody goes into a receivership or starts stops cultivating those assets eventually find somebody that’s got the great idea that their brand is going to be better than everybody else and they’re so efficient that everybody’s going to line up to get their product, which we know is not a reality, but you’re facing that. The question Trevor and I always talk about is, at what point in time does that stop? And I think you’re seeing some of that with other people in the industry with these sale leasebacks and how do they unwind. I think that’s still the big challenge. So simply put, I think the fundamentals of Arizona are good.

It’s growing in population. There’s a lot of activity in Arizona as you probably are well aware of. And we think that’s still a positive. There’s still people moving into the state and into the city of Phoenix primarily. But until cultivation gets underhand, I think we’re going to have that pricing pressure here, which again, Matt supports our model, which is we don’t produce and try to sell into the wholesale market.

We try to make sure our demand matches our supply. It’s a balance. So we’re never forced really to have find a home for product.

Matt Bottomley, Analyst, Canaccord Genuity: Got it. Thanks for that. And then just maybe more broadly on strategy on sort of the next twelve or so months here. I think in the last two years on a free cash flow basis, you guys pretty consistent maybe between $1,000,000 and $2,000,000. So just with the increases in Ohio, I think you had mentioned staying free cash flow positive and servicing debt, but I’d imagine there’s some increased capital spend there.

So maybe just how to balance those two things or to get an understanding of what the capital requirements are to hit your Ohio goals?

Eric Hoffendurger, Chief Executive Officer, VEX Sciences: Well, I’ll give you the 40,000 foot look and Trevor will give you a little bit more detail on it. But from our standpoint, we think that everything is pretty well lined up and it really works out well. And as Trevor mentioned in his comments, our objective is by the end of twenty twenty six is to only have mortgage backed debt that is really low cost and it continues to come down. So I’ll let Trevor give you a little bit more granular right now on it, Matt, to answer your question.

Trevor Smith, Chief Financial Officer, VEX Sciences: Yes, a little bit higher continuing maintenance CapEx just because we got the additional assets in Ohio, but we’re not expecting that to exceed $2,000,000 a year. We’ll have some build out CapEx related to the Ohio retails, which as we mentioned in our comments are going to be self funded.

Matt Bottomley, Analyst, Canaccord Genuity: Okay. And then just last sort of maintenance question kind of for me is, is there anything to expect several quarters out here as Ohio is a higher proportion of your total top line just in terms of your margin profile. I know prices come down in Arizona. You had mentioned some pricing declines in Ohio, but I imagine that’s earlier days because it just sort of got off the market and there’s some volatility there. So any upside to overall margin profile as Ohio takes up a higher proportion into 2026?

Trevor Smith, Chief Financial Officer, VEX Sciences: Yes. We certainly think so, Matt. And it’s probably not for the reason you’re expecting, which is early markets with higher pricing. We think it’s more so that as we get to an eight store location, we’re going to be faster to getting to 100% vertical sell through, which will have a natural improvement over margin versus going to the wholesale market.

Matt Bottomley, Analyst, Canaccord Genuity: Okay. That’s it for me. Thanks, everyone.

Conference Operator: The next question comes from Pablo Zwanich with Zwanich and Associates. Please go ahead.

: Thank you. Good morning, everyone. Eric, regarding Ohio, it’s a bit of a three part question in terms of regulations. Do we know the timing of when adult use rules will come out? Do we have a sense of what those rules will look like?

I mean, is there some consensus or is it all over the map? And then number three, maybe for the audience, remind us what will be so different? I mean, what will really make a difference in terms of those rules compared to what you have right now in terms of the non medical market? Thank you.

Eric Hoffendurger, Chief Executive Officer, VEX Sciences: So on the rules, Pablo, we don’t have a clue. The legislation still has you see different things going back and forth of whether they’re going to increase the tax rate, not increase the tax rate. Looks like they’re not going to do that. The commission still seems to be very good to work with and they are very easy to work with. I think they’re just backlogged on what they’re getting through.

But I think we’ll get some clarity in the next, I’m guessing, two months that the legislation will finally be clear of what’s going to happen. Are they going to change the potency and restrict it, all that kind of stuff. So I think that’s still a pretty gray area for us, but we’ll see. Now as far as the last part of your question, I think the biggest thing for us is going to be advertising and it looks like that’s still up in the air. Some of the stores, how do you get the population to know that they’re there?

You read some surveys that say 40% of the population still doesn’t realize they have legal cannabis, adult use cannabis program. So that’s going to take some time. I think as more stores come on in the marketplace and different things happen, some of that will start to go through. But we could get that a lot faster if we could do some type of advertising or outreach to that store front. So to me, that’s the biggest challenge.

Obviously, adding new product like pre rolls and some of that stuff, that will help too because that’s usually a little bit of a different consumer price entrance point. And I think that will make people a little bit more coming into the store storefront. So we think that’s going to be helpful too.

: Understood. But just to be clear, in terms of your existing customer base, I mean, those consumers that go to your dispensaries, you can stay in touch with them through your loyalty programs and through email and text I suppose for that cannot be done either in Ohio.

Eric Hoffendurger, Chief Executive Officer, VEX Sciences: Yes, you can do that. I mean the loyalty program can offer any like cash off discounts or anything you have to almost like coupon it to cannabis space at this point in

: time.

Eric Hoffendurger, Chief Executive Officer, VEX Sciences: And yes, you’re promoting to them with emails that are your specials and everything. It’s a matter of expansion, of expanding that customer base. Our stores do very well on retention and we track that. So that’s in the high percentage of

: how many customers we see on a reoccurring basis

Eric Hoffendurger, Chief Executive Officer, VEX Sciences: and stuff like that. Percentage of how many customers we see on a reoccurring basis and stuff like that. And we watch the frequency that they come in. In traditional retail, KPIs and metrics that you watch. So that’s been pretty positive in Ohio and that’s tracked with Arizona.

That consumer still tends to stay within a region and a district. That’s why we like the rural stores too because that customer base is more loyal to the store because you don’t have the geographic overlaps, right? So as long as you provide a good product, good service, good pricing, you tend to maintain that customer a lot more loyal where they’re not jumping from shop to shop within a large metro area.

: Got it. And then in terms of the eight stores, I know you said opening in 2025 and some early twenty twenty six. I don’t know if you can give more granularity in terms of how many do you expect to have by end of 2Q, end of 3Q, end of 4Q? Are all the eight stores going to be rural, some larger, smaller or that’s still unclear? Do you know where all the stores are going to be?

If you can give more color that would be helpful. Thank you.

Eric Hoffendurger, Chief Executive Officer, VEX Sciences: Yes. I think the best color I can give you right now is to tell you, it’s a lot of it’s predicated on regulation. So we have map pins in the state. So somebody could get this as public information. We will be in Portsmouth, we’ll be down around the Cincinnati area, we’ll have another store in the Columbus Metro Area and then we’ll have one in that Portsmouth that we talked about.

So the way we really see it, we’ll have like three regions. We’ll have Columbus, Cincinnati and then Southeast Ohio will be where the stores are located. And we think that that’s good geography for us. Again, we operate the business as traditional manufacturing distribution type of a business under our commodity. So I always like to have my locations within like a two, two point five hour radius of where my manufacturing plan is in order to keep logistical issues down.

I think that’s a big play for us. And then as Trevor mentioned, as wholesale becomes less of a critical function, but not a function that we ignore, but it’s just less of a priority for us or a need. That also lends well to that too is that we keep ourselves to do that thing. So we don’t have all that logistics to deal with and added cost, especially on a commodity as you well are aware. Freight on a commodity really kills your business.

: Thank you. And one very last one. Regarding Kentucky, anything you can say there? I mean, we saw Cresco, I think they signed up an agreement with one of our largest cultivators there, I think it’s MSA. What’s the opportunity for you in Kentucky for that being or no focus there, just Arizona, Ohio?

Thank you.

Eric Hoffendurger, Chief Executive Officer, VEX Sciences: Okay. So in the MD and A, you’ll see in the discussion on Kentucky under subsequent event that we did get the process for licensing Kentucky. So we have that. We have transferred 100% of the vape in Kentucky, which was the CBD operation over to our ownership. And we will be making a decision of what we do in Kentucky in the immediate future.

So we’re kind

Trevor Smith, Chief Financial Officer, VEX Sciences: of

Eric Hoffendurger, Chief Executive Officer, VEX Sciences: exploring what’s it look like, what’s it going to take to operate in Kentucky the best way that makes the most sense for us. So that’s an ongoing discussion right now and that’s in the MD and A as a subsequent event.

: Got it. Thank you.

Eric Hoffendurger, Chief Executive Officer, VEX Sciences: Thank you.

Conference Operator: The next question comes from Paul Penney with Partner Capital Group. Please go ahead.

: Hey, good morning, Eric and Trevor. Can you give more color on the wholesale margins in Ohio? And in terms of how long do you expect to be in the wholesale business in Ohio?

Eric Hoffendurger, Chief Executive Officer, VEX Sciences: Well, I’ll let Trevor talk about the margin profile a little bit. But as far as like being in there, Trevor also hit that in his comments, Paul. We anticipate by the time we get to Store 8, the need to be in the wholesale market is not there. From a purely business standpoint, if you just were saying that you could absorb your whole supply, that doesn’t mean we’ll exit the wholesale market. That just means that we get to participate in it based upon a want, not a need.

And we prefer to be in that position. We think that’s the better strategic position to be in and a better match, especially as you watch cultivation in this space. People tend to produce too much and they don’t really control it. And a lot of them have this fixed cost and they kind of think that they’re going to leverage down that fixed cost versus what the variable is going to do and stuff along those lines. So we think there’s opportunity within that when you have the retail door.

So that’s kind of the maximum of Ohio when we get to the eight stores, we’re at the max and if we can do more, great. Now that doesn’t mean we won’t align with somebody that we have a relationship with and try to support that sell through because we always do like to have alternatives in the stores for the consumer and stuff along those lines. We recognize the importance of that. But it gets back to that desire to do it versus the need that you have to do it. So I’ll let Trevor address the margins a little bit for you.

Trevor Smith, Chief Financial Officer, VEX Sciences: Good morning, Paul. Ohio as a percentage wholesale was about just under 30% for 2024. That compares to sub 10 in Arizona for a product mix. We’re expecting product mix to continue to decline in Ohio, particularly as new retails come online. I’d expect it to drop probably under 20 with 26 probably mirroring Arizona is under 10%.

So at the end of the day, we’re pretty much only expecting to have to move finished goods to the wholesale market. We’re not seeing significant price appreciation, at least not yet. So I’d say the kind of margins are probably more in line with the medical margins that you were seeing about a year ago.

: Okay, great. That’s helpful. And then switching gears, very impressive cash flow. And thank you so much for highlighting that, one of the few companies that do that. Do you expect this to continue?

Maybe just, Trevor, just a little more color. I’m still a little gray on CapEx requirements for the year for 2025. And separately, is there any change in your tax strategy in terms of accruing for taxes and not paying them?

Trevor Smith, Chief Financial Officer, VEX Sciences: I’ll take the second question first. No change from last quarter, still under audit, still working with counsel, still don’t have any uncertain tax positions on the balance sheet? Great. And then CapEx, yes. Yes.

Maintenance CapEx, as I said earlier, I’d say you guys under $2,000,000 a year. These are both brand new facilities on the cultivation side with Eloy in Ohio. Growth in expansion CapEx, I’m budgeting a little bit more than this just to be safe from my projections, but you’re looking at just about $1,000,000 a store to add the four new stores on.

Conference Operator: Great.

: Yes. I think that’s One

Eric Hoffendurger, Chief Executive Officer, VEX Sciences: thing I’d add on that too, Paul, for you that I think is helpful is, look at how we’ve announced and then financed them. So we’ve done some mortgage backed stuff at 10% interest rates or lower interest rates and then we do some stuff with the capital on that and the cash flow. So we’re very fortunate that we have some good relationships with shareholders and other people that have helped structure this to make it a little bit more advantageous as you’re bringing them on versus they start to generate revenue, right? So we do have some stuff in place, which I think makes it pretty nice for us.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.